Elsevier Inc.

SHERPA: Unknown

People

  1. Rosen
    Rosen
  2. Derkach
    Derkach
  3. Giralt
    Giralt
  4. Hassoun
    Hassoun
  5. Hultcrantz
    Hultcrantz
  6. Iyengar
    Iyengar
  7. Korde
    Korde
  8. Lesokhin
    Lesokhin
  9. Mailankody
    Mailankody
  10. Shah
    Shah

Groups

  1. Breast Medicine Service (12)
  2. Department of Medicine (12)
  3. Sloan Kettering Institute Faculty (12)
  4. Solid Tumor Oncology Division (12)
  5. GSK Faculty (11)
  6. Molecular Pharmacology and Chemistry Program Faculty (8)
  7. Sloan Kettering Institute Postdocs (6)
  8. Hematologic Malignancies, Division of (5)
  9. Center for Hematologic Malignancies (4)
  10. GME, Medicine (4)
Search Within
  1. "Meeting abstract"
  2. "Breast Medicine Service"
  3. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (12)
Groups
  1. Breast Medicine Service (12)
  2. Department of Medicine (12)
  3. Sloan Kettering Institute Faculty (12)
  4. Solid Tumor Oncology Division (12)
  5. GSK Faculty (11)
  6. Molecular Pharmacology and Chemistry Program Faculty (8)

More Groups

People
  1. Neal Rosen (8)
  2. Alexander Lesokhin (3)
  3. Andriy Derkach (3)
  4. Carlyn Rose Tan (3)
  5. Hani Hassoun (3)
  6. Malin Hultcrantz (3)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2018 (1)
  5. 2012 (3)
  6. 2002 (3)

More Years

Publications
  1. European Journal of Cancer (8)
  2. Clinical Lymphoma, Myeloma and Leukemia (3)
  3. Gynecologic Oncology (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A whole foods plant-based weight loss intervention improves metabolic and immune biomarkers in MGUS/SMM patients as well as progression trajectory in a subset: The NUTRIVENTION trial
    Meeting Abstract

    Shah, U.; Derkach, A.; Castro, F.; Anuraj, A.; Blaslov, J.; Hosszu, K.; Pollak, M.; Mailankody, S.; Korde, N.; Tan, C. R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • A pilot plant based dietary intervention in MGUS and SMM is feasible and associated with reduction in insulin and leptin levels
    Meeting Abstract

    Shah, U.; Castro, F.; Anuraj, A.; Blaslov, J.; Adintori, P.; Derkach, A.; Pollak, M.; Maclachlan, K.; Mailankody, S.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Providing nutritional guidance for patients with plasma cell disorders - A missed opportunity for hematologists and oncologists?
    Meeting Abstract

    Sweeney, N.; Malik, M.; Jafri, M.; Derkach, A.; Chmielewski, C.; Adintori, P.; Mailankody, S.; Korde, N.; Tan, C.; Hassoun, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • PLX8394 selectively disrupts BRAF-dimers and RAS-independent BRAF mutant-driven signaling
    Meeting Abstract

    Yao, Z.; Gao, Y.; Su, W.; Yaeger, R.; Na, N.; Zhang, Y.; Zhang, C.; Rymar, A.; Tao, A.; Torres, N.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • BAY80-6946 is a potent and selective PI3K inhibitor that induces apoptosis in breast cancers by blocking AKT and non-AKT PI3K effector pathways
    Meeting Abstract

    Will, M.; Toy, W.; Patel, P.; Rodrik-Outmezguine, V.; Schneider, C.; Paul, J.; Liu, N.; Rosen, N.; Chandarlapaty, S.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Resistance to RAF inhibitors due to RAS-independent dimerization of BRAF(V600E) splicing variants
    Meeting Abstract

    Poulikakos, P. I.; Persaud, Y.; Janakiraman, M.; Gabay, M. T.; Dahlman, K. B.; Sosman, J. A.; Ribas, A.; Lo, R. S.; Rosen, N.; Solit, D. B.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • A mechanistic logic for dual targeting of HER2 and PI3K/AKT/mTOR signaling in HER2 amplified breast cancer
    Meeting Abstract

    Chandarlapaty, S.; Rodrik-Outmezguine, V.; Scaltriti, M. M.; Sakr, R.; Will, M.; Giri, D.; Hudis, C.; Baselga, J.; King, T.; Rosen, N.
    European Journal of Cancer (2012)

    Fulltext@MSK | Save
  • Ansamycins inactivate AKT and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D.; Basso, A.; Munster, P.; Scher, H.; Rosen, N.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • A novel class of pyridopyrimidine tyrosine kinase inhibitors blocks cancer cells in the S-phase of the cell cycle
    Meeting Abstract

    Mizenina, O.; Moasser, M.; Rosen, N.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • 17AAG low target binding affinity and potent whole cell potency: Finding an explanation
    Meeting Abstract

    Chiosis, G.; Huezo, H.; Rosen, N.; Mimnaugh, E.; Neckers, L.; Whitesell, L.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save